Bleeding Risk During Oral Biopsies in Patients on Blood Thinners
Part of Blood & lymphatic, Mouth & dental clinical trials.
This study looks at whether patients taking certain blood-thinning medications (DOACs) have more bleeding during oral biopsies—small tissue samples taken from the mouth. Understanding this helps doctors know how to safely care for patients on these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign the consent form yourself
- Your doctor has recommended taking a biopsy (small tissue sample) from inside your mouth
- You do not have an inherited or acquired bleeding disorder (like hemophilia or von Willebrand disease)
- You do not have very low platelet counts or advanced liver disease
- You are not taking other blood-thinning medications besides possibly low-dose aspirin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the timing of hip fracture surgery affects the need for blood transfusions in patients taking blood thinners (DOACs). It might help guide better care for people on these medications.
This research study looks at people with antiphospholipid syndrome (APS) who have taken or are taking direct oral anticoagulants (DOACs), which are blood thinners. The goal is to collect information about their treatment and health over time.
This study compares bleeding after common endoscopic procedures (like colonoscopy or upper endoscopy) between people who take blood thinners and those who don't. It may help doctors better understand risks for patients on anticoagulants.
This study compares whether you should temporarily stop your blood thinner (DOAC) or keep taking it when you have an elective heart catheter test or procedure (coronary angiography or PCI). It aims to see which approach is safer and better for preventing bleeding and clotting around the procedure.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Hear when a new Direct Oral Anticoagulants (DOACs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.